---
title: "PRKAG2"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene: PRKAG2"
tags: ['PRKAG2', 'Cardiomyopathy', 'AMPK', 'MissenseMutation', 'SymptomaticTreatment', 'CMH6', 'GeneticPosition', 'EnergyHomeostasis']
---

# Gene: PRKAG2

## Information

* Genetic Position: Chr. 7 (7q36.1)
* Pathology: Cardiomyopathy
* Function: PRKAG2 gene encodes for a regulatory subunit of AMP-activated protein kinase (AMPK), a protein that is involved in cellular energy homeostasis and stress response.
* Aliases: 5'-AMP-activated protein kinase subunit gamma-2, AMPK gamma-2 chain, Gamma-2 regulatory subunit of AMPK

## General Details

* HGNC ID: HGNC: 9398
* NCBI Entrez Gene ID: 51422
* Ensembl ID: ENSG00000106871
* OMIM ID: 602743
* UniProtKB/Swiss-Prot ID: O95396

## Mutation Details

* AA Mutation: c.179C>T
* Mutation Type: Missense
* dbSNP ID: rs28931594

## Somatic SNVs/InDels

No somatic SNVs/InDels found for this gene.

## Related Disease

* Cardiomyopathy, familial hypertrophic, 6 (CMH6)

## Treatment and Prognosis

Treatment of PRKAG2-associated cardiomyopathy is symptomatic. There is currently no cure for the condition.

## Drug Response

No information available on drug response.

## Related Papers

* Subject: PRKAG2
* Author: Arad, M., Benson, D. W., Perez-Atayde, A. R., McKenna, W. J., Sparks, E. A., Kanter, R. J., McGarry, K., Seidman, J. G., & Seidman, C. E.
* DOI: 10.1016/S0002-9149(01)01702-6
* Title: Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy
* Journal: The American Journal of Cardiology
* Date: 2002

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**